<DOC>
	<DOCNO>NCT02245490</DOCNO>
	<brief_summary>Study evaluate efficacy tamsulosin storage symptom detrusor motor activity patient LUTS suggestive BPH relevant storage symptom</brief_summary>
	<brief_title>Study Characterise Effect Tamsulosin Lower Urinary Tract Symptoms ( LUTS ) Detrusor Motor Activity Patients Affected Benign Prostatic Hyperplasia ( BPH ) Storage Urinary Symptoms</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Male outpatient age 5080 year LUTS suggestive BPH Medical history : storage symptom ( frequency , urgency ) least 6 month Urinary Chart : At least 8 micturition per 24 hour average , week screening period ( check urinary chart Visit 2 ) Urgency ( strong desire void ) : least per 24 hour average , week screening period ( check urinary chart Visit 2 ) IPSS ≥ 13 randomisation ( Visit 3 ) Qmax : &gt; 4 ml/sec randomisation ( Visit 3 ) , void volume least 150 ml Prostate Specific Antigen ( PSA ) &lt; 2.5 ng/ml 2.5 10 ng/ml , cancer rule usual procedure centre ( Visit 1 ; result Visit 3 ) Written Informed Consent participation study Patients known history diagnosis time screen visit ( Visit 1 ) follow condition : Urological disturbance Medical history pelvic surgery Palpable bladder physical examination , residue urinary volume &gt; 400 ml Known neurological bladder disorder Bladder neck stenosis Urethral stricture Bladder prostatic cancer Bladder stone Severe diverticulum bladder Symptomatic urinary tract infection last month , recurrent urinary tract infection ( 2 last year ) Haematuria unknown origin Diseases may affect micturition ( i.e. , diabetes mellitus ) Cardiovascular disease ( occur last 6 month ) Myocardial infarction Instable angina Clinically significant ventricular arrhythmia Heart failure ( NYHA class III/IV ) Orthostatic hypotension Cerebral stroke Neurological disease ( severity might compromise correct performance trial ) Senile dementia Multiple sclerosis Parkinson 's disease Psychiatric disturbances Hepatic renal insufficiency ( biochemistry value 15 % outside normal lab range , regard clinically relevant investigator ) Clinically significant abnormality haematological , blood chemistry urinary value evidence sample take screen visit ( Visit 1 ) Patients take take αblockers BPH hypertension , phytotherapy BPH within previous 6 week Patients take take : αblockers BPH hypertension within previous 4 week phytotherapy BPH mepartricin within previous 4 week finasteride within previous 6 month anticholinergic within previous 4 week antidiuretic within previous 4 week concomitant drug may influence pharmacodynamic pharmacokinetic property tamsulosin . In particular : αblockers mixed αβblockers , α agonist , anticholinergic Patients take part clinical study within previous 3 month Patients hypersensitivity allergic reaction previously prescribe α blocker ( ) Patients judge investigator inappropriate inclusion study</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>